7:30 Registration open

8:00 Registration and Panelist Check-in

8:30 - 10:15 Embryonic and Induced Pluripotent Stem Cells

Moderator: Pearl O'Rourke, M.D., Director of Human Research Affairs, Partner Healthcare Systems

Renee Reijo Pera, Ph.D., Stanford University

Roger Pedersen, Ph.D., University of Cambridge

Sheng Ding, Ph.D., The Scripps Research Institute

10:15-10:30 Coffee break

10:30 - 12:15 Funding Mechanisms and Regulation

Moderator: Susan Stayn, J.D., Senior University Counsel, Stanford University

Story Landis, Ph.D., Director of NINDS, Chair of the NIH Stem Cell Task Force

Robert Klein, J.D., Chair, The California Institute of Regenerative Medicine

Robert Goldstein, M.D., Ph.D., Senior V.P. of Scientific Affairs, Juvenile Diabetes Research Foundation

Link to Audio Recording of this Session: Funding Mechanisms and Regulation

12:15 - 1:30 Lunch and Keynote Address:

Irving Weissman, M.D., Director of the Institute of Stem Cell Biology and Regenerative Medicine, Stanford University

Link to Audio Recording of this Session: Keynote

1:30 - 3:15 Stem Cell Clinical Trials

Moderator: Hank Greeley, J.D., Stanford University

Thomas Okarma, M.D., Ph.D., C.E.O., Geron 

Judith Shizuru, M.D., Stanford University 

Insoo Hyun, Ph.D., Case Western Reserve University

Hank Greeley, J.D., Stanford University

Link to Audio Recording of this Session: Stem Cell Clinical Trials

3:15-3:30 Coffee Break

3:30 - 5:15 Intellectual Property Considerations

Moderator: Brenda Simon, J.D., Stanford University

Robin Feldman, J.D., University of California, Hastings College of Law

Esther Kepplinger, B.S., Director of Patent Operations, Wilson Sonsini Goodrich & Rosati

David Earp, J.D., Ph.D., Senior V.P. Business Development and I.P., Geron

Aurora Plomer, Ph.D., University of Sheffield

Link to Audio Recording of this Session: Intellectual Property Considerations

5:30 - 6:30 Reception and Poster Session in Cooley Courtyard